The problem of axillary staging in breast cancer after neoadjuvant chemotherapy. Role of targeted axillary dissection and types of lymph node markers

被引：5
|
作者：
Flores-Funes, Diego [1 ,4 ]
Aguilar-Jimenez, Jose [1 ,4 ]
Martinez-Galvez, Maria [2 ,4 ]
Jose Ibanez-Ibanez, Maria [3 ]
Carrasco-Gonzalez, Luis [1 ,4 ]
Ignacio Gil-Izquierdo, Jose [2 ,4 ]
Luis Aguayo-Albasini, Jose [1 ,4 ]
机构：
[1] Hosp Gen Univ JM Morales Meseguer, Serv Cirugia Gen, Murcia, Spain
[2] Hosp Gen Univ JM Morales Meseguer, Serv Radiodiagnost, Murcia, Spain
[3] Hosp Gen Univ JM Morales Meseguer, Med Nucl, Murcia, Spain
[4] Univ Murcia, Fac Med, IMIB Arrixaca, Campus Excelencia Int Mare Nostrum, Murcia, Spain
来源：
CIRUGIA ESPANOLA | 2020年 / 98卷 / 09期
关键词：
Breast cancer; Neoadjuvant chemotherapy; Sentinel lymph node biopsy; Targeted axillary dissection; Wire location; Intraoperative ultrasound; Radioioidine seed; Ferromagnetic seed; TUMOR-LOCALIZATION; WIRE LOCALIZATION; CLIPPED NODE; THERAPY; IDENTIFICATION; MARKING; SURGERY; BIOPSY; FEASIBILITY; ACCURACY;
D O I：
10.1016/j.ciresp.2020.03.012
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
Targeted axillary dissection (TAD) consists of a new axillary staging technique that combines sentinel lymph node biopsy (SLNB) and clipped lymph node biopsy (CLNB) in the same surgery, in order to re-stage patients with breast cancer and positive axillary lymph nodes undergoing neoadjuvant chemotherapy (NAQT). Prior to the NAQT, the affected lymph node is punctured and a solid marker is left inside echo-guided, in order to biopsy it in the subsequent surgery. There are numerous types of markers: metallic (steel, titanium or polyglycolic acid clips), radioiodine or ferromagnetic seeds, which differ in the method of location (wire, gamma-detection or magnetic probe). The aim of this study is to perform a systematic review about the current status of the TAD, as well as to explain the different techniques and types of axillary marking, based on the current available evidence. (C) 2020 AEC. Published by Elsevier Espana, S.L.U. All rights reserved.
引用
收藏
页码：510 / 515
页数：6
相关论文
共 50 条
  • [1] Targeted Axillary Dissection After Neoadjuvant Chemotherapy: Redefining Lymph Node Management in Breast Cancer
    Bonfili, D.
    Listorti, C.
    Pilotta, F.
    Maugeri, I.
    Ceccarossi, V.
    Ferraris, C.
    Gennaro, M.
    Virgilio, E.
    Folli, S.
    BREAST, 2025, 80
  • [2] The sentinel lymph node as a viable alternative to axillary lymph node dissection after neoadjuvant breast cancer chemotherapy. A diagnostic accuracy analysis
    Alvarez, M. Merayo
    Martinez, B. Alonso
    Rodriguez, D. Calvo
    del Olmo, D. Ortiz
    Folgueras, M. A. Llaneza
    CIRUGIA ESPANOLA, 2023, 101 (07): : 510 - 512
  • [3] Wire guided localisation for targeted axillary node dissection is accurate in axillary staging in node positive breast cancer following neoadjuvant chemotherapy
    Balasubramanian, Rajesh
    Morgan, Catrin
    Shaari, Elina
    Kovacs, Tibor
    Pinder, Sarah E.
    Hamed, Hisham
    Sever, Ali R.
    Kothari, Ashutosh
    EJSO, 2020, 46 (06): : 1028 - 1033
  • [4] Axillary Lymph Node Dissection Should Not Be Avoided in Patients Who Undergo Neoadjuvant Chemotherapy for a Positive Sentinel Node after Targeted Axillary Staging
    Amersi, Farin
    Boyle, Marissa K.
    Rahimtoola, Rhea
    Chung, Alice
    Dang, Catherine
    Karlam, Scott
    Phillips, Edward
    Yuan, Yuan
    Jang, Julie
    Shiao, Stephen L.
    Giuliano, Armando E.
    Tseng, Joshua
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (01) : S91 - S91
  • [5] Axillary lymph node dissection after neoadjuvant chemotherapy for node-positive breast cancer.
    Van Zeeland, M.
    Westhoff, P.
    Wauters, C.
    Bult, P.
    Werner, A.
    Laurens, N.
    Strobbe, L.
    Meijer, H.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S519 - S519
  • [6] Is Axillary Radiation not Inferior to Axillary Dissection for Sentinel Lymph Node-Positive Breast Cancer After Neoadjuvant Chemotherapy?
    Khan, Tahsin M.
    Rossi, Alexander J.
    Suman, Vera
    Haffty, Bruce
    Hernandez, Jonathan M.
    Boughey, Judy C.
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (03) : 1526 - 1527
  • [7] Is Axillary Radiation not Inferior to Axillary Dissection for Sentinel Lymph Node-Positive Breast Cancer After Neoadjuvant Chemotherapy?
    Tahsin M. Khan
    Alexander J. Rossi
    Vera Suman
    Bruce Haffty
    Jonathan M. Hernandez
    Judy C. Boughey
    Annals of Surgical Oncology, 2022, 29 : 1526 - 1527
  • [8] Axillary lymph node dissection is not required for breast cancer patients with minimal axillary residual disease after neoadjuvant chemotherapy
    Muslumanoglu, Mahmut
    Mollavelioglu, Baran
    Cabioglu, Neslihan
    Emiroglu, Selman
    Tukenmez, Mustafa
    Karanlik, Hasan
    Ozmen, Tolga
    Yilmaz, Ravza
    Comert, Rana Gunoz
    Onder, Semen
    Bayram, Aysel
    Simsek, Duygu Has
    Oflas, Melis
    Ibis, Kamuran
    Aydiner, Adnan
    Ozmen, Vahit
    Igci, Abdullah
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2024, 22 (01)
  • [9] Is it always necessary to perform an axillary lymph node dissection after neoadjuvant chemotherapy for breast cancer?
    Osorio-Silla, I
    Gomez Valdazo, A.
    Sanchez Mendez, J., I
    York, E.
    Diaz-Almiron, M.
    Gomez Ramirez, J.
    Rivas Fidalgo, S.
    Oliver, J. M.
    Alvarez, C. M.
    Hardisson, D.
    Diaz Miguel, M.
    Lobo, F.
    Diaz Dominguez, J.
    ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND, 2019, 101 (03) : 186 - 192
  • [10] Is Pathologic Axillary Staging Valid If Lymph Nodes Are Less than 10 with Axillary Lymph Node Dissection after Neoadjuvant Chemotherapy?
    Choi, Hee Jun
    Ryu, Jai Min
    Lee, Jun Ho
    Bang, Yoonju
    Oh, Jongwook
    Chae, Byung-Joo
    Nam, Seok Jin
    Kim, Seok Won
    Lee, Jeong Eon
    Lee, Se Kyung
    Yu, Jonghan
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (21)
12345